Griseofulvin therapy was reported to be effective in the treatment of tinea unguium, although a longer course of treatment was required than that suggested in earlier reports on the efficacy of the drug.
There are only a few reports on the clinical evaluation of griseofulvin for tinea unguium based on long-term follow -up studies.
To evaluate griseofulvin therapy, a retrospective survey was carried out on tinea unguium patients who visited Sakai Municipal Hospital in 1992. Three hundred and ten of these patients were treated with oral griseofulvin (0.5g/day). 161 patients dropped out before complete cure was achieved, and 31 currently remain under treatment. Complete cure was recorded in 19 individuals with tinea unguium of the fingernail and in 62 with the tinea unguium of the toenail.
Within one year, complete cure was recorded in nine patients with fingernail infection and in 26 with toenail infection, and within two years in 16 and 48, respectively.
Continued treatment with oral griseofulvin achieved an overall cure rate of about 80% within two years. No change in the liver function test was observed.
Treatment was stopped in eleven patients because of adverse reactions, namely headache, gastric distress or drug eruptions, which immediately ceased with when the drug was discontinued.
Treatment of tinea unguium with oral itraconazole, oral terbinafine and fulconazole were briefly reviewed. The efficacy of these newly developed oral antifungal agents has not yet been completely evaluated.
Mechanical and chemical avulsion, and topical agents are helpful in treatment of tinea unguim. Combination of topical and systemic therapy may raise the cure rate of this disease and make it one which is more frequently curable in future.
View full abstract